Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kai Rothaus

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Diagnostics (Basel, Switzerland)|November 26, 2022
The Architecture of Macular Neovascularizations Predicts Treatment Responses to Anti-VEGF Therapy in Neovascular AMDHenrik Faatz, Kai Rothaus, Martin Ziegler, et al.
The Journal of Rheumatology|March 17, 2020
Enthesitis-related Arthritis: Prevalence and Complications of Associated Uveitis in Children and Adolescents From a Population-based Nationwide Study in GermanyKaroline Walscheid, Karen Glandorf, Kai Rothaus, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|July 1, 2020
[Influence of CNV vascular morphology in exudative age-related macular degeneration on development of visual acuity and need for anti-VEGF therapy after 1 year]Henrik Faatz, Marie-Louise Gunnemann, Kai Rothaus, et al.
The British Journal of Ophthalmology|January 8, 2021
Incidence and phenotypical variation of outer retina-associated hyperreflectivity in macular telangiectasia type 2Stefanie Mueller, Frederic Gunnemann, Kai Rothaus, et al.
American Journal of Ophthalmology|December 4, 2025
Cataract Surgery with IOL Implantation in Children with Chronic Anterior Uveitis Associated with Juvenile Idiopathic Arthritis (JIA) or Antinuclear Antibody (ANA)-Positive Uveitis: Mid-term Results and Predictors for OutcomeCharlotte Wortmann, Johanna Backes, Kai Rothaus, et al.
Klinische Monatsblatter Fur Augenheilkunde|September 13, 2017
[OCT Angiography in Exudative AMD with Detachment of Vascularised Retinal Pigment Epithelium]Frederic Gunnemann, Kai Rothaus, Marie-Louise Farecki, et al.
Klinische Monatsblatter Fur Augenheilkunde|October 26, 2019
[Analysis of the "Portal" Care Model - Examination of the Outcome Quality of IVOM Therapy with Regard to Latency Periods in Exudative AMD]Kai Rothaus, Marie-Louise Farecki, Peter Mussinghoff, et al.
Eye (London, England)|April 12, 2019
Optical coherence tomography angiography of types 1 and 2 choroidal neovascularization in age-related macular degeneration during anti-VEGF therapy: evaluation of a new quantitative methodHenrik Faatz, Marie-Louise Farecki, Kai Rothaus, et al.
Biomedicines|March 25, 2022
Vascular Analysis of Type 1, 2, and 3 Macular Neovascularization in Age-Related Macular Degeneration Using Swept-Source Optical Coherence Tomography Angiography Shows New Insights into Differences of Pathologic Vasculature and May Lead to a More Personalized UnderstandingHenrik Faatz, Kai Rothaus, Martin Ziegler, et al.
Pediatric Rheumatology Online Journal|July 11, 2026
Janus kinase inhibitors are of limited use in refractory JIA-associated uveitis: retrospective data from a tertiary uveitis centerKaroline Baquet-Walscheid, Charlotte Wortmann, Kai Rothaus, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Diagnostics (Basel, Switzerland)|November 26, 2022
The Architecture of Macular Neovascularizations Predicts Treatment Responses to Anti-VEGF Therapy in Neovascular AMDHenrik Faatz, Kai Rothaus, Martin Ziegler, et al.
The Journal of Rheumatology|March 17, 2020
Enthesitis-related Arthritis: Prevalence and Complications of Associated Uveitis in Children and Adolescents From a Population-based Nationwide Study in GermanyKaroline Walscheid, Karen Glandorf, Kai Rothaus, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|July 1, 2020
[Influence of CNV vascular morphology in exudative age-related macular degeneration on development of visual acuity and need for anti-VEGF therapy after 1 year]Henrik Faatz, Marie-Louise Gunnemann, Kai Rothaus, et al.
The British Journal of Ophthalmology|January 8, 2021
Incidence and phenotypical variation of outer retina-associated hyperreflectivity in macular telangiectasia type 2Stefanie Mueller, Frederic Gunnemann, Kai Rothaus, et al.
American Journal of Ophthalmology|December 4, 2025
Cataract Surgery with IOL Implantation in Children with Chronic Anterior Uveitis Associated with Juvenile Idiopathic Arthritis (JIA) or Antinuclear Antibody (ANA)-Positive Uveitis: Mid-term Results and Predictors for OutcomeCharlotte Wortmann, Johanna Backes, Kai Rothaus, et al.
Klinische Monatsblatter Fur Augenheilkunde|September 13, 2017
[OCT Angiography in Exudative AMD with Detachment of Vascularised Retinal Pigment Epithelium]Frederic Gunnemann, Kai Rothaus, Marie-Louise Farecki, et al.
Klinische Monatsblatter Fur Augenheilkunde|October 26, 2019
[Analysis of the "Portal" Care Model - Examination of the Outcome Quality of IVOM Therapy with Regard to Latency Periods in Exudative AMD]Kai Rothaus, Marie-Louise Farecki, Peter Mussinghoff, et al.
Eye (London, England)|April 12, 2019
Optical coherence tomography angiography of types 1 and 2 choroidal neovascularization in age-related macular degeneration during anti-VEGF therapy: evaluation of a new quantitative methodHenrik Faatz, Marie-Louise Farecki, Kai Rothaus, et al.
Biomedicines|March 25, 2022
Vascular Analysis of Type 1, 2, and 3 Macular Neovascularization in Age-Related Macular Degeneration Using Swept-Source Optical Coherence Tomography Angiography Shows New Insights into Differences of Pathologic Vasculature and May Lead to a More Personalized UnderstandingHenrik Faatz, Kai Rothaus, Martin Ziegler, et al.
Pediatric Rheumatology Online Journal|July 11, 2026
Janus kinase inhibitors are of limited use in refractory JIA-associated uveitis: retrospective data from a tertiary uveitis centerKaroline Baquet-Walscheid, Charlotte Wortmann, Kai Rothaus, et al.
Pageof 6